Bcl-2 overexpression in melanoma cells increases tumor progression-associated properties and in vivo tumor growth
✍ Scribed by Daniela Trisciuoglio; Marianna Desideri; Ludovica Ciuffreda; Marcella Mottolese; Domenico Ribatti; Angelo Vacca; Mario Del Rosso; Lucia Marcocci; Gabriella Zupi; Donatella Del Bufalo
- Book ID
- 102314165
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 408 KB
- Volume
- 205
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
In this study, we demonstrated that bcl‐2 overexpression in human melanoma cells consistently enhanced the activity of multiple metastasis‐related proteinases, in vitro cell invasion, and in vivo tumor growth. In particular, by using the M14 parental cell line, the MN8 control clone, and two bcl‐2 overexpressing derivatives, we found that bcl‐2 overexpressing cells exposed to hypoxia, when compared to parental cells, expressed higher level of several metalloproteases (MMPs) such as MMP‐2, MMP‐7, MT1‐MMP, and tissue inhibitors of metalloproteases‐1 and ‐2. Moreover, bcl‐2 overexpression in melanoma cells enhanced in vitro invasion on matrigel and, in vivo tumor growth. The more aggressive behavior of bcl‐2 transfectants tumors is significantly associated to an increase in MMP‐2 expression as well as in a more elevated microvessel density as compared to the parental line. Taken together, our data suggest that bcl‐2 plays a pivotal role in the regulation of molecules associated with the migratory and invasive phenotype, contributing, in cooperation to hypoxia, to tumor progression. © 2005 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract The hypothesis tested in the study suggests that mechanisms of the earlier described delayed or accelerated tumor progression may be regulated by the antiapoptotic and proapoptotic cellular programs activated in stress reactions of transformed cells to the host normal cellular environme
a,-Macroglobulin ( a 2 M ) is known as an inhibitor of various proteinases and to bind several of the growth factors. W e previously demonstrated that clonal variation exists in the production of a,M in a human melanoma and that this variation may be associated with growth stimulation. We have now a